383 filings
10-Q
2024 Q1
OMER
Omeros Corporation
Quarterly report
15 May 24
4:09pm
8-K
OMER
Omeros Corporation
15 May 24
Omeros Corporation Reports First Quarter 2024 Financial Results
4:07pm
DEF 14A
OMER
Omeros Corporation
Definitive proxy
29 Apr 24
5:23pm
ARS
2023 FY
OMER
Omeros Corporation
29 Apr 24
Annual report to shareholders
5:22pm
10-K
2023 FY
OMER
Omeros Corporation
Annual report
1 Apr 24
5:20pm
8-K
03xi0v5 6a
1 Apr 24
Omeros Corporation Reports Fourth Quarter and Year-End 2023 Financial Results
4:06pm
8-K
bdddf6ai
7 Feb 24
Entry into a Material Definitive Agreement
8:00am
8-K
zbukr4twjfyp 7v
9 Nov 23
Omeros Corporation Reports Third Quarter 2023 Financial Results
4:05pm
8-K
89fw oi5c
16 Oct 23
Omeros Corporation Provides Update on Interim Analysis of ARTEMIS-IGAN Phase 3 Trial of Narsoplimab in IgA Nephropathy
4:36pm
S-8
u1gu3xh 6f
9 Aug 23
Registration of securities for employees
5:20pm
8-K
6zsudzcnexo3292i
9 Aug 23
Omeros Corporation Reports Second Quarter 2023 Financial Results
8:00am
8-K
4nse ng1ju
28 Jun 23
Departure of Directors or Certain Officers
5:25pm
ARS
aety4m0ek
17 May 23
Annual report to shareholders
5:06pm
8-K
afvj5mc6z7j5qyrcb
16 May 23
Departure of Directors or Certain Officers
5:10pm
8-K
7xw at492e
9 May 23
Omeros Corporation Reports First Quarter 2023 Financial Results
4:05pm